Moroni, FrancescaDwyer, Benjamin JGraham, CatrionaPass, ChloeBailey, LauraRitchie, LisaMitchell, DonnaGlover, AlisonLaurie, AudreyDoig, StuartHargreaves, EmilyFraser, Alasdair RTurner, Marc LCampbell, John D MMcGowan, Neil W ABarry, JacquelineMoore, Joanna KHayes, Peter CLeeming, Diana JNielsen, Mette JMusa, KishwarFallowfield, Jonathan AForbes, Stuart J2020-04-062020-04-062019-10Moroni, F, Dwyer, B J, Graham, C, Pass, C, Bailey, L, Ritchie, L, Mitchell, D, Glover, A, Laurie, A, Doig, S, Hargreaves, E, Fraser, A R, Turner, M L, Campbell, J D M, McGowan, N W A, Barry, J, Moore, J K, Hayes, P C, Leeming, D J, Nielsen, M J, Musa, K, Fallowfield, J A & Forbes, S J 2019, 'Safety profile of autologous macrophage therapy for liver cirrhosis', Nature Medicine, vol. 25, pp. 1560-1565. https://doi.org/10.1038/s41591-019-0599-81078-8956https://hdl.handle.net/2164/13978This work was supported by a Medical Research Council UK grant (Biomedical Catalyst Major Awards Committee; reference MR/M007588/1) to S.J. Forbes. We thank Z.M. Younossi (Center for Outcomes Research in Liver Diseases, Washington, DC, USA) for academic use of the CLDQ instrument and L.J. Fallowfield (Sussex Health Outcomes Research & Education in Cancer (SHORE-C), University of Sussex, UK) for advice about health-related quality of life assessment.6839879176416112433185766engSDG 3 - Good Health and Well-beingregenerationtranslational researchDIAGNOSISMARKERDISEASEINJURYFUNCTIONAL-CHARACTERIZATIONCELL THERAPYDUCTULAR REACTIONSTRANSPLANTATIONR MedicineGeneral Biochemistry,Genetics and Molecular BiologyMedical Research Council (MRC)MR/M007588/1Supplementary DataRJournal article10.1038/s41591-019-0599-8http://www.scopus.com/inward/record.url?scp=85074194479&partnerID=8YFLogxK25